US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

4.68

+0.15003.31%

Post-market: 4.680.00000.00%19:58 EST

Volume:129.65K

Turnover:594.21K

Market Cap:114.87M

PE:-1.44

High:4.69

Open:4.53

Low:4.44

Close:4.53

52wk High:7.36

52wk Low:1.47

Shares:24.54M

Float Shares:5.38M

Volume Ratio:1.09

T/O Rate:2.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2458

EPS(LYR):-5.8064

ROE:-47.96%

ROA:-28.76%

PB:0.89

PE(LYR):-0.81

Loading ...

Overview Company News Filings

Artiva Biotherapeutics Names Elaine Sorg to Board of Directors

Artiva (ARTV): Off‑the‑Shelf AlloNK Platform Positions Lead RA Program for Pivotal De‑Risking and Attractive Risk‑Reward

Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Artiva Biotherapeutics, Inc. (ARTV) and Oncolytics Biotech (ONCY)

Artiva Biotherapeutics Highlights AlloNK Cost-Effectiveness and Durability in New Clinical Trial Data

Artiva Biotherapeutics CEO Fred Aslan Reports Sale of Common Shares

US Stocks Mixed; NY Manufacturing Activity Dips In December

Artiva Biotherapeutics Replaces Underwater Stock Options with RSUs for Key Executives

Artiva Biotherapeutics CEO Fred Aslan Reports Sale of Common Shares

Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development

Promising Developments in Artiva Biotherapeutics’ AlloNK Therapy for Autoimmune Diseases

Artiva Biotherapeutics Is Maintained at Buy by HC Wainwright & Co.

Buy Rating for Artiva Biotherapeutics, Inc. Based on Promising Clinical Results and Competitive Edge

Buy Rating for Artiva Biotherapeutics Based on Promising AlloNK Combination Therapy Results

BUZZ-U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold miners

BUZZ-U.S. STOCKS ON THE MOVE-ExxonMobil, Yatra, Venture Global

Artiva Biotherapeutics Reports Positive AlloNK Trial Results

Artiva Biotherapeutics announces safety, translational data from AlloNK

Artiva Biotherapeutics Announces Positive Initial Data for AlloNK Cell Therapy in Autoimmune Disease Trials

Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion With Allonk® in Autoimmune Disease

THOMSON REUTERS

Artiva Biotherapeutics Q3 EPS $(0.88), Inline

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ARTV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARTV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":4.68,"timestamp":1771621200000,"preClose":4.53,"halted":0,"volume":129652,"hourTrading":{"tag":"盘后","latestPrice":4.68,"preClose":4.68,"latestTime":"19:58 EST","volume":202,"amount":923.6569,"timestamp":1771635484471,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03311258278145683,"floatShares":5381708,"shares":24544904,"eps":-3.245753,"marketStatus":"Market Closed","change":0.15,"latestTime":"02-20 16:00:00 EST","open":4.53,"high":4.69,"low":4.4405,"amount":594214.5638,"amplitude":0.055077,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.245753,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"listingDate":1721361600000,"exchange":"NASDAQ","adjPreClose":4.53,"preHourTrading":{"tag":"盘前","latestPrice":4.55,"preClose":4.53,"latestTime":"09:25 EST","volume":4127,"amount":19097.9624058,"timestamp":1771597540077,"change":0.02,"changeRate":0.004415,"amplitude":0.028698},"postHourTrading":{"tag":"盘后","latestPrice":4.68,"preClose":4.68,"latestTime":"19:58 EST","volume":202,"amount":923.6569,"timestamp":1771635484471,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0888129930521024},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","floatShares":5381708,"roa":"-28.76%","roe":"-47.96%","lyrEps":-5.806365,"volumeRatio":1.0888129930521024,"shares":24544904,"dividePrice":0,"high":4.69,"amplitude":0.055077,"preClose":4.53,"low":4.4405,"week52Low":1.47,"pbRate":"0.89","week52High":7.36,"institutionHeld":0,"latestPrice":4.68,"eps":-3.245753,"divideRate":0,"volume":129652,"delay":0,"ttmEps":-3.245753,"open":4.53,"prevYearClose":4.29,"prevWeekClose":4,"prevMonthClose":3.89,"prevQuarterClose":4.29,"fiveDayClose":3.99,"twentyDayClose":4.95,"sixtyDayClose":3.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"ARTV","fiscalQuarterEnding":"2025/09","expectedEps":-0.92,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.88},{"market":"US","date":"2025-08-06","symbol":"ARTV","fiscalQuarterEnding":"2025/06","expectedEps":-0.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.87},{"market":"US","date":"2025-05-08","symbol":"ARTV","fiscalQuarterEnding":"2025/03","expectedEps":-0.68,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.83}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1735621200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARTV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARTV","date":"2026-02-20","current":-1.441884,"percent":0.48062,"low":-11.820615,"twenty":-4.858976,"median":-1.356118,"eighty":-0.88623,"high":-0.499349,"avg":-3.035273,"sd":3.269356,"marketCap":111188415},"quantilePoints":[{"date":"2024-08-02","current":-10.391793,"twenty":-10.391793,"median":-10.391793,"eighty":-10.391793,"marketCap":269833291},{"date":"2024-08-09","current":-9.862789,"twenty":-10.391793,"median":-10.042112,"eighty":-9.943484,"marketCap":256097171},{"date":"2024-08-16","current":-10.185571,"twenty":-10.248334,"median":-10.131774,"eighty":-9.95245,"marketCap":264478532},{"date":"2024-08-23","current":-8.939273,"twenty":-10.248334,"median":-10.051078,"eighty":-9.342751,"marketCap":232117163},{"date":"2024-08-30","current":-8.088598,"twenty":-10.185571,"median":-9.943484,"eighty":-9.046867,"marketCap":263081639},{"date":"2024-09-06","current":-8.893463,"twenty":-10.142533,"median":-9.800025,"eighty":-8.930111,"marketCap":289259885},{"date":"2024-09-13","current":-8.019798,"twenty":-10.131774,"median":-9.459311,"eighty":-8.763533,"marketCap":260843926},{"date":"2024-09-20","current":-8.759053,"twenty":-10.07439,"median":-9.028935,"eighty":-8.450238,"marketCap":284888199},{"date":"2024-09-27","current":-9.946342,"twenty":-10.07439,"median":-9.323455,"eighty":-8.581333,"marketCap":323504758},{"date":"2024-10-04","current":-11.499524,"twenty":-10.277026,"median":-9.57298,"eighty":-8.727691,"marketCap":374022017},{"date":"2024-10-11","current":-10.566121,"twenty":-10.505561,"median":-9.728296,"eighty":-8.794895,"marketCap":343663087},{"date":"2024-10-18","current":-9.543111,"twenty":-10.587029,"median":-9.800025,"eighty":-8.869568,"marketCap":310389700},{"date":"2024-10-25","current":-7.586699,"twenty":-10.505561,"median":-9.574426,"eighty":-8.581333,"marketCap":246757383},{"date":"2024-10-31","current":-7.579232,"twenty":-10.485041,"median":-9.464706,"eighty":-8.226879,"marketCap":246514511},{"date":"2024-11-08","current":-10.424244,"twenty":-10.485041,"median":-9.3863,"eighty":-8.226879,"marketCap":339048530},{"date":"2024-11-15","current":-4.166082,"twenty":-10.46953,"median":-9.378833,"eighty":-8.149728,"marketCap":255280837},{"date":"2024-11-22","current":-4.310765,"twenty":-10.439178,"median":-9.30416,"eighty":-7.969021,"marketCap":264146442},{"date":"2024-11-29","current":-5.065892,"twenty":-10.411264,"median":-9.046867,"eighty":-7.81669,"marketCap":310417611},{"date":"2024-12-06","current":-4.598149,"twenty":-10.334409,"median":-8.970887,"eighty":-7.365669,"marketCap":281756204},{"date":"2024-12-13","current":-4.233469,"twenty":-10.223229,"median":-8.939273,"eighty":-5.058757,"marketCap":259410023},{"date":"2024-12-20","current":-3.963922,"twenty":-10.173512,"median":-8.885996,"eighty":-4.852633,"marketCap":242893280},{"date":"2024-12-27","current":-4.17401,"twenty":-10.150694,"median":-8.781454,"eighty":-4.667914,"marketCap":255766623},{"date":"2025-01-03","current":-3.95203,"twenty":-10.131774,"median":-8.549971,"eighty":-4.598149,"marketCap":242164600},{"date":"2025-01-10","current":-4.066984,"twenty":-10.131774,"median":-8.396892,"eighty":-4.398368,"marketCap":249208505},{"date":"2025-01-17","current":-2.687539,"twenty":-10.07439,"median":-8.17661,"eighty":-4.337719,"marketCap":164681643},{"date":"2025-01-24","current":-2.477451,"twenty":-10.049285,"median":-8.109405,"eighty":-4.224748,"marketCap":151808300},{"date":"2025-01-31","current":-2.140518,"twenty":-10.011532,"median":-8.012331,"eighty":-4.193829,"marketCap":131162371},{"date":"2025-02-07","current":-1.823404,"twenty":-9.967928,"median":-7.881014,"eighty":-4.108209,"marketCap":111730908},{"date":"2025-02-14","current":-1.589533,"twenty":-9.948785,"median":-7.698708,"eighty":-3.978192,"marketCap":97400205},{"date":"2025-02-21","current":-1.502326,"twenty":-9.945199,"median":-7.508293,"eighty":-3.804572,"marketCap":92056553},{"date":"2025-02-28","current":-1.478543,"twenty":-9.911206,"median":-5.18038,"eighty":-2.77871,"marketCap":90599193},{"date":"2025-03-07","current":-2.0216,"twenty":-9.837683,"median":-5.059946,"eighty":-2.521847,"marketCap":123875572},{"date":"2025-03-14","current":-2.219796,"twenty":-9.795827,"median":-4.998506,"eighty":-2.343471,"marketCap":136020236},{"date":"2025-03-21","current":-1.601424,"twenty":-9.736345,"median":-4.76067,"eighty":-2.165887,"marketCap":98128885},{"date":"2025-03-28","current":-1.319282,"twenty":-9.624289,"median":-4.665536,"eighty":-2.054897,"marketCap":86245441},{"date":"2025-04-04","current":-0.946604,"twenty":-9.574715,"median":-4.606077,"eighty":-1.965312,"marketCap":61882322},{"date":"2025-04-11","current":-0.685729,"twenty":-9.561032,"median":-4.439593,"eighty":-1.797242,"marketCap":44828138},{"date":"2025-04-17","current":-0.857161,"twenty":-9.511749,"median":-4.37617,"eighty":-1.744126,"marketCap":56035173},{"date":"2025-04-25","current":-0.913063,"twenty":-9.383313,"median":-4.344458,"eighty":-1.606181,"marketCap":59689641},{"date":"2025-05-02","current":-0.883248,"twenty":-9.365642,"median":-4.233469,"eighty":-1.560992,"marketCap":57740592},{"date":"2025-05-09","current":-0.740531,"twenty":-9.335033,"median":-4.213649,"eighty":-1.495984,"marketCap":53111599},{"date":"2025-05-16","current":-0.723546,"twenty":-9.26085,"median":-4.193829,"eighty":-1.480232,"marketCap":51893443},{"date":"2025-05-23","current":-0.672592,"twenty":-9.079462,"median":-4.170046,"eighty":-1.376675,"marketCap":48238975},{"date":"2025-05-30","current":-0.696371,"twenty":-9.046867,"median":-4.104641,"eighty":-1.177664,"marketCap":49944393},{"date":"2025-06-06","current":-0.665798,"twenty":-9.028935,"median":-3.995633,"eighty":-0.946604,"marketCap":47751713},{"date":"2025-06-13","current":-0.696371,"twenty":-8.975602,"median":-3.957976,"eighty":-0.913063,"marketCap":49944393},{"date":"2025-06-20","current":-0.570684,"twenty":-8.968058,"median":-3.829149,"eighty":-0.909336,"marketCap":40930039},{"date":"2025-06-27","current":-0.533318,"twenty":-8.961769,"median":-2.822312,"eighty":-0.881757,"marketCap":38250096},{"date":"2025-07-03","current":-0.546906,"twenty":-8.947831,"median":-2.762854,"eighty":-0.830328,"marketCap":39224621},{"date":"2025-07-11","current":-0.60805,"twenty":-8.911787,"median":-2.592405,"eighty":-0.73948,"marketCap":43609983},{"date":"2025-07-18","current":-0.879805,"twenty":-8.888983,"median":-2.477451,"eighty":-0.736237,"marketCap":63100478},{"date":"2025-07-25","current":-1.168544,"twenty":-8.885996,"median":-2.34466,"eighty":-0.73948,"marketCap":83809129},{"date":"2025-08-01","current":-1.019079,"twenty":-8.836712,"median":-2.219796,"eighty":-0.740531,"marketCap":73089357},{"date":"2025-08-08","current":-0.856075,"twenty":-8.776974,"median":-2.136554,"eighty":-0.74119,"marketCap":64318634},{"date":"2025-08-15","current":-0.877783,"twenty":-8.664966,"median":-2.104843,"eighty":-0.766227,"marketCap":65949557},{"date":"2025-08-22","current":-0.90054,"twenty":-8.539516,"median":-2.017636,"eighty":-0.794855,"marketCap":67659360},{"date":"2025-08-29","current":-1.027331,"twenty":-8.461857,"median":-1.938358,"eighty":-0.806285,"marketCap":77185407},{"date":"2025-09-05","current":-1.011075,"twenty":-8.405106,"median":-1.906646,"eighty":-0.809828,"marketCap":75964119},{"date":"2025-09-12","current":-0.864778,"twenty":-8.31765,"median":-1.769891,"eighty":-0.816568,"marketCap":64972526},{"date":"2025-09-19","current":-0.773749,"twenty":-8.226879,"median":-1.740162,"eighty":-0.790778,"marketCap":58133313},{"date":"2025-09-26","current":-0.978565,"twenty":-8.17661,"median":-1.635118,"eighty":-0.805192,"marketCap":73521543},{"date":"2025-10-03","current":-0.959059,"twenty":-8.149728,"median":-1.601424,"eighty":-0.809828,"marketCap":72055997},{"date":"2025-10-10","current":-0.975314,"twenty":-8.101082,"median":-1.571695,"eighty":-0.816568,"marketCap":73277286},{"date":"2025-10-17","current":-0.90054,"twenty":-8.061078,"median":-1.530074,"eighty":-0.825779,"marketCap":67659360},{"date":"2025-10-24","current":-1.573506,"twenty":-8.013824,"median":-1.539983,"eighty":-0.830317,"marketCap":118220688},{"date":"2025-10-31","current":-1.280912,"twenty":-7.969021,"median":-1.537745,"eighty":-0.833281,"marketCap":96237502},{"date":"2025-11-07","current":-1.11836,"twenty":-7.90156,"median":-1.498363,"eighty":-0.837688,"marketCap":84024621},{"date":"2025-11-14","current":-1.102105,"twenty":-7.858868,"median":-1.490435,"eighty":-0.847643,"marketCap":82803333},{"date":"2025-11-21","current":-0.982565,"twenty":-7.819676,"median":-1.476561,"eighty":-0.856509,"marketCap":77807345},{"date":"2025-11-28","current":-1.16544,"twenty":-7.765913,"median":-1.457948,"eighty":-0.858684,"marketCap":92288839},{"date":"2025-12-05","current":-1.170089,"twenty":-7.585206,"median":-1.427209,"eighty":-0.865066,"marketCap":92657012},{"date":"2025-12-12","current":-0.973266,"twenty":-7.550856,"median":-1.356118,"eighty":-0.866579,"marketCap":77070998},{"date":"2025-12-19","current":-1.441302,"twenty":-7.413459,"median":-1.35655,"eighty":-0.869582,"marketCap":114133803},{"date":"2025-12-26","current":-1.332817,"twenty":-7.317879,"median":-1.35655,"eighty":-0.875795,"marketCap":105543087},{"date":"2026-01-02","current":-1.329717,"twenty":-5.60788,"median":-1.355686,"eighty":-0.876285,"marketCap":105297638},{"date":"2026-01-09","current":-1.419605,"twenty":-5.08879,"median":-1.356118,"eighty":-0.877508,"marketCap":112415660},{"date":"2026-01-16","current":-1.38241,"twenty":-5.065892,"median":-1.373111,"eighty":-0.877783,"marketCap":109470271},{"date":"2026-01-23","current":-1.534289,"twenty":-5.058757,"median":-1.38241,"eighty":-0.877783,"marketCap":121497274},{"date":"2026-01-30","current":-1.286323,"twenty":-5.046865,"median":-1.38396,"eighty":-0.878996,"marketCap":101861351},{"date":"2026-02-06","current":-1.199535,"twenty":-5.015947,"median":-1.373111,"eighty":-0.880542,"marketCap":94988778},{"date":"2026-02-13","current":-1.23673,"twenty":-4.922398,"median":-1.361731,"eighty":-0.882362,"marketCap":97934166},{"date":"2026-02-20","current":-1.404107,"twenty":-4.858976,"median":-1.356118,"eighty":-0.88623,"marketCap":111188415}],"updateTime":1771770719099},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARTV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612407714","title":"Artiva Biotherapeutics Names Elaine Sorg to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2612407714","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612407714?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:00","pubTimestamp":1771506048,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Inc. appointed Elaine Sorg to its Board of Directors. Sorg brings more than 35 years of biopharmaceutical leadership and commercialization experience, including senior roles at AbbVie and Eli Lilly, and has helped lead launches of immunology therapies such as Humira and Rinvoq.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on February 19, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL7Xnznl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU1127390331.HKD","SG9999017495.SGD","LU1732799900.SGD","IE00B775H168.HKD","LU1023059063.AUD","LU0472753341.HKD","LU2168564065.EUR","LU2210149790.SGD","ARTV","IE00B19Z3B42.SGD","LU1267930730.SGD","LU1585245621.USD","LU1712237335.SGD","LU2237443622.USD","IE00BVYPNV92.GBP","LU0122379950.USD","LU1496350502.SGD","LU2211815571.USD","LU0203202063.USD","LU0511384066.AUD","LU2237443465.HKD","LU2746668974.SGD","LU0683600562.USD","LU2106854487.HKD","LU0114720955.EUR","IE00B1XK9C88.USD","LU0545039389.USD","BK4588","IE00BJT1NW94.SGD","BK4533","LU0310799852.SGD","LU2023250504.SGD","SG9999015945.SGD","LU2133065610.SGD","LU0323591593.USD","LU1839511570.USD","LU1934455277.USD","LU2491049909.HKD","LU0094547139.USD","IE0002141913.USD","LU0385154629.USD","SG9999011175.SGD","IE00B3PB1722.GBP","IE00BWXC8680.SGD","IE00B3QW5Z07.USD","LU0820561909.HKD","LU2237443549.SGD","IE00B7KXQ091.USD","LU0289961442.SGD","LU0640476718.USD","SG9999018865.SGD","LU0820562030.AUD","LU2750360641.GBP","LU2468319806.SGD","LU1551013342.USD","IE00BFTCPJ56.SGD","LU0738911758.USD","IE00BK4W5L77.USD","LLYZ","SG9999014914.USD","SGXZ81514606.USD","LU0266013472.USD","LU0069063385.USD","LU1814569148.SGD","LU2361045086.USD","LU2896262040.SGD","IE00B4JS1V06.HKD","LU0912757837.SGD","LU0466842654.USD","LU2461242641.AUD","LU2471134523.USD","SG9999014880.SGD","LU0096364046.USD","IE0009355771.USD","IE0005OL40V9.USD","LU2108987350.USD","LU2129689514.USD","LU0861579265.USD","LU2237443895.HKD","LU0965508806.USD","LU1366192091.USD","LU1035775433.USD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU2324357040.USD","LU2756315664.SGD","LU2213496289.HKD","LU2023251221.USD","LU1718418525.SGD","LU1037948541.HKD","LU2028103732.USD","LU2491050071.SGD","IE00BFSS8Q28.SGD","LU0964807845.USD","IE00BJLML261.HKD","SGXZ99366536.SGD","LU1929549753.HKD","LU0029864427.USD","LU1934455194.USD","SGXZ31699556.SGD","LU1003077747.HKD","LU1430594728.SGD","LU0795875169.SGD","LU0320765992.SGD","LU2491050154.USD","LU2347655156.SGD","LU2063271972.USD","LU0234572021.USD","BK4559","LU0006306889.USD","LU0943347566.SGD","LU1064131342.USD","LU1989771016.USD","LU2271345857.HKD","LU1804176565.USD","LU2361044865.SGD","LU1069344957.HKD","LU1720051108.HKD","SG9999003800.SGD","LU2087621335.USD","IE00B64PRP62.GBP","LU0158827948.USD","LU2210150020.SGD","IE00BLSP4452.SGD","LU1974910355.USD","LU0471298777.SGD","SG9999014005.SGD","LU1868836591.USD","LU0353189763.USD","BK4112","LU1988902786.USD","LU0553294199.USD","LU2236285917.USD","LU2417539215.USD","SG9999001176.USD","LU0170899867.USD","BK4139","LU1074936037.SGD","IE00BFSS7M15.SGD","LU2095319765.USD","LU1145028129.USD","LU2265009873.SGD","LU1093756168.USD","LU1868837136.USD","LU1629891620.HKD","LU0965509101.SGD","LU0203347892.USD","LU1057294990.SGD","BK4581","IE00B2B36J28.USD","IE00BN8TJ469.HKD","LU1917777945.USD","IE00B1BXHZ80.USD","LU1162221912.USD","LU2089284900.SGD","BK4534","IE0004445015.USD","LU1551013425.SGD","IE00BJJMRX11.SGD","LU0965509283.SGD","LU0234570918.USD","SG9999015978.USD","LU0310800379.SGD","LU2168564149.EUR","LU0795875086.SGD","IE0002270589.USD","IE0004445239.USD","SG9999014013.SGD","IE00BJJMRZ35.SGD","IE00BN29S564.USD","LU0882574139.USD","LU2023250330.USD","LU0889565916.HKD","LU0098860793.USD","SG9999001440.SGD","LU2089984988.USD","LU0985320562.USD","LU0965509010.AUD","LU0079474960.USD","LU0354030511.USD","LU0432979614.USD","LU0238689110.USD","LU0109391861.USD","LU0353189680.USD","SG9999014906.USD","LU2750360997.AUD","LU0823434740.USD","LU1037948897.HKD","LU0109394709.USD","LU2456880835.USD","LU2602419157.SGD","LU0708995401.HKD","LU2471134796.USD","LU0211328371.USD","LU2471134952.CNY","LU2462157665.USD","LU0823434583.USD","LU0320765646.SGD","LU1934455863.HKD","LU2129689605.HKD","BK4007","LU1323610961.USD","LU2089283258.USD","SG9999013999.USD","LU0128525929.USD","LU2756315318.SGD","LU1989772923.USD","LU0124676726.USD","IE00BDGV0183.EUR","LU0708994859.HKD","LU2168564495.EUR","LU0057025933.USD","LU0689472784.USD","IE00BK4W5M84.HKD","LU0820561818.USD","LU2360106947.USD","LU0203345920.USD","LU0787776722.HKD","LU1732800096.USD","LU1548497426.USD","LU0316494557.USD","LU1868836757.USD","LU1244550494.USD","IE00BGHQF631.EUR","LU0097036916.USD","LU2237443382.USD","LU2357305700.SGD","LU2361044949.HKD","IE00BVYPNW00.USD","LU0289739699.SGD","SG9999018857.SGD","LU1061106388.HKD","LU0203201768.USD","LU0823416689.USD","SG9999014898.SGD","GB00BDT5M118.USD","LU1232071149.USD","SG9999014039.USD","LU2111349929.HKD","BK4585","LU1983299246.USD","BK4599","SGXZ51526630.SGD","LU2552382132.HKD","LU0289739343.SGD","LU2129689431.USD","LU1244550577.SGD","ELIL","IE00BLSP4239.USD","IE00B19Z3581.USD","LU1291159041.SGD","IE00BJJMRY28.SGD","LU0225283273.USD","LU0354030438.USD","LU0672654240.SGD","LU0058720904.USD","BK4516","ELIS","LU1623119135.USD","IE00B42XCP33.USD","SG9999015986.USD","LU2237438978.USD","LU2552382058.USD","LU1267930573.SGD","LU1989772840.SGD","LU2746668461.USD","LU0256863902.USD","LU1868836914.USD","LU0210536198.USD","SGXZ57979304.SGD","LU0211327993.USD","LU0456855351.SGD","LU2237443978.SGD","LU0417517546.SGD","LU2471134879.HKD","LU2552382215.SGD","LU0661504455.SGD","LU1280957306.USD","LU2112291526.USD","LU0949170772.SGD","LU1720051017.SGD","LU1267930490.SGD","LU0061475181.USD","SG9999014021.USD","LLYX","LU2168563687.JPY","LU2168564222.USD","LU0198837287.USD","SG9999001176.SGD","LU1496350171.SGD","LU1244550221.USD","LU0158827781.USD","LU2264538146.SGD","LU0471298694.HKD","SG9999015952.SGD","BK4550","LU1868837300.USD","BK4566","IE00BKPKM429.USD","IE00BKDWB100.SGD","LU0314104364.USD","LU0256863811.USD","LU0320765059.SGD","LU2087625088.SGD","LU0786609619.USD","LU0106261372.USD","IE00BSNM7G36.USD","IE00BGHQF748.EUR","LU0689626769.HKD","IE00BBT3K403.USD"],"gpt_icon":0},{"id":"2612106214","title":"Artiva (ARTV): Off‑the‑Shelf AlloNK Platform Positions Lead RA Program for Pivotal De‑Risking and Attractive Risk‑Reward","url":"https://stock-news.laohu8.com/highlight/detail?id=2612106214","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612106214?lang=en_us&edition=fundamental","pubTime":"2026-02-18 19:37","pubTimestamp":1771414647,"startTime":"0","endTime":"0","summary":"In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on Artiva Biotherapeutics, Inc., with a price target of $15.0...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/artiva-artv-off‑the‑shelf-allonk-platform-positions-lead-ra-program-for-pivotal-de‑risking-and-attractive-risk‑reward-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/artiva-artv-off‑the‑shelf-allonk-platform-positions-lead-ra-program-for-pivotal-de‑risking-and-attractive-risk‑reward-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV","RA"],"gpt_icon":0},{"id":"2605481145","title":"Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Artiva Biotherapeutics, Inc. (ARTV) and Oncolytics Biotech (ONCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605481145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605481145?lang=en_us&edition=fundamental","pubTime":"2026-01-22 00:40","pubTimestamp":1769013615,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Trevi Therapeutics (TRVI – Research Report), Artiva ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trevi-therapeutics-trvi-artiva-biotherapeutics-inc-artv-and-oncolytics-biotech-oncy-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trevi-therapeutics-trvi-artiva-biotherapeutics-inc-artv-and-oncolytics-biotech-oncy-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV","ONCY","BK4585","BK4007","BK4137","BK4588","LABU","XLV","BK4581","XBI","HCSG","BK4139","LU0029874061.USD","TRVI","LU0128526141.USD"],"gpt_icon":0},{"id":"2605021271","title":"Artiva Biotherapeutics Highlights AlloNK Cost-Effectiveness and Durability in New Clinical Trial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2605021271","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605021271?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:00","pubTimestamp":1769000434,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Inc. announced upcoming presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, scheduled for February 4-7, 2026, in Salt Lake City, Utah. The company will present new data on the cost-effectiveness of its off-the-shelf NK cell therapy, AB-101 , in outpatient community rheumatology practices, highlighting its comparison to CAR-T treatments for rheumatologic diseases. Additionally, updated results on the continued durability of AlloNK in patients with relapsed or refractory Non-Hodgkin Lymphoma will be shared. These results will be presented as poster sessions during the conference and have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDLbQJJGk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4139","LU2210150020.SGD","SG9999014005.SGD","SG9999014013.SGD","SG9999014039.USD","BK4112","LU2095319765.USD","IE00B3QW5Z07.USD","NDAQ","SG9999014021.USD","BK4585","IE00BGHQF748.EUR","ARTV","BK4588","IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2591719356","title":"Artiva Biotherapeutics CEO Fred Aslan Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2591719356","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591719356?lang=en_us&edition=fundamental","pubTime":"2025-12-16 10:20","pubTimestamp":1765851602,"startTime":"0","endTime":"0","summary":"Fred Aslan, President and CEO of Artiva Biotherapeutics Inc., reported a disposal of common shares of Artiva Biotherapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 15, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDLb5JZFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Artiva Biotherapeutics CEO Fred Aslan Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2591647230","title":"US Stocks Mixed; NY Manufacturing Activity Dips In December","url":"https://stock-news.laohu8.com/highlight/detail?id=2591647230","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591647230?lang=en_us&edition=fundamental","pubTime":"2025-12-15 23:02","pubTimestamp":1765810978,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/12/49394249/us-stocks-mixed-ny-manufacturing-activity-dips-in-december","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QLD","BK4585","IRBT","AMCI","TQQQ","NQmain","MASK","BK4139","MNQmain","USAW.SI",".IXIC","IRBTQ","BK4187","PSQ","BK4547","SQQQ","MNTS","BK4209","ARTV","BK4567","NVIW.SI","BK4604","USJW.SI","BK4191","TSYW.SI","QID","BK4134"],"gpt_icon":1},{"id":"2591684221","title":"Artiva Biotherapeutics Replaces Underwater Stock Options with RSUs for Key Executives","url":"https://stock-news.laohu8.com/highlight/detail?id=2591684221","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591684221?lang=en_us&edition=fundamental","pubTime":"2025-12-13 06:24","pubTimestamp":1765578272,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Inc. has implemented a new equity compensation arrangement for select employees, including President and CEO Fred Aslan and COO Jennifer Bush. Under Option for RSU Exchange Agreements, eligible participants were given a one-time opportunity to exchange outstanding stock options with exercise prices above the current market value for restricted stock units  granted under the 2024 Equity Incentive Plan. As part of the exchange, Dr. Aslan surrendered options for 869,136 shares and received an equivalent number of RSUs, while Ms. Bush exchanged options for 84,877 shares for RSUs. The RSUs granted in exchange for vested options will vest in installments between August 2026 and February 2027, with full acceleration possible upon certain termination events. RSUs granted for unvested options will vest between August 2026 and February 2029, with partial acceleration in specific circumstances. The RSU grants became effective on December 12, 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL69fXnL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2584860926","title":"Artiva Biotherapeutics CEO Fred Aslan Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584860926","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584860926?lang=en_us&edition=fundamental","pubTime":"2025-11-18 09:38","pubTimestamp":1763429907,"startTime":"0","endTime":"0","summary":"Fred Aslan, President and CEO of Artiva Biotherapeutics Inc., reported a disposal of common shares of Artiva Biotherapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL4DHCKF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Artiva Biotherapeutics CEO Fred Aslan Reports Sale of Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2583532521","title":"Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2583532521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583532521?lang=en_us&edition=fundamental","pubTime":"2025-11-13 12:42","pubTimestamp":1763008921,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics, Inc. ( ($ARTV) ) has released its Q3 earnings. Here is a breakdown of the information Artiva Biotherapeutics, Inc. presente...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/artiva-biotherapeutics-reports-increased-losses-amid-ongoing-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/artiva-biotherapeutics-reports-increased-losses-amid-ongoing-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2583258591","title":"Promising Developments in Artiva Biotherapeutics’ AlloNK Therapy for Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2583258591","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583258591?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:35","pubTimestamp":1762983351,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren has maintained their bullish stance on ARTV stock, giving a Buy rating today. Tyler Van Buren has given his Buy ra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-in-artiva-biotherapeutics-allonk-therapy-for-autoimmune-diseases-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-in-artiva-biotherapeutics-allonk-therapy-for-autoimmune-diseases-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2583644304","title":"Artiva Biotherapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2583644304","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583644304?lang=en_us&edition=fundamental","pubTime":"2025-11-13 03:03","pubTimestamp":1762974180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARTV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 12, 2025 14:03 ET (19:03 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"gpt_icon":0},{"id":"2583301404","title":"Buy Rating for Artiva Biotherapeutics, Inc. Based on Promising Clinical Results and Competitive Edge","url":"https://stock-news.laohu8.com/highlight/detail?id=2583301404","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583301404?lang=en_us&edition=fundamental","pubTime":"2025-11-13 02:25","pubTimestamp":1762971924,"startTime":"0","endTime":"0","summary":"In a report released today, Gil Blum from Needham reiterated a Buy rating on Artiva Biotherapeutics, Inc., with a price target of $18.00. Gil Blum ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-artiva-biotherapeutics-inc-based-on-promising-clinical-results-and-competitive-edge-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-artiva-biotherapeutics-inc-based-on-promising-clinical-results-and-competitive-edge-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV"],"gpt_icon":0},{"id":"2583306727","title":"Buy Rating for Artiva Biotherapeutics Based on Promising AlloNK Combination Therapy Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583306727","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583306727?lang=en_us&edition=fundamental","pubTime":"2025-11-13 01:05","pubTimestamp":1762967129,"startTime":"0","endTime":"0","summary":"Emily Bodnar, an analyst from H.C. Wainwright, maintained the Buy rating on Artiva Biotherapeutics, Inc.. The associated price target was raised to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-artiva-biotherapeutics-based-on-promising-allonk-combination-therapy-results-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-artiva-biotherapeutics-based-on-promising-allonk-combination-therapy-results-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV"],"gpt_icon":0},{"id":"2582303647","title":"BUZZ-U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold miners","url":"https://stock-news.laohu8.com/highlight/detail?id=2582303647","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582303647?lang=en_us&edition=fundamental","pubTime":"2025-11-12 23:56","pubTimestamp":1762962963,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold minersEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL6N3WO0T2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FND","BROS","LCID","LU0096364046.USD","VLN","CWAN","LU2471134879.HKD","BBWI","BHF","BK4179","NEM","T","VG","LU0208291251.USD","BHVN","AMD","CREX","CRWS","LU0788109394.HKD","ARTV","LU2471134523.USD","LWAY","LU0795875086.SGD","LU0278409577.USD","CRMD","MBRX","FLNG","YTRA","PBF","FTCI","LB","VVX","LU1223082196.USD","LU0823421416.USD","BKR","XOM","LU0882574055.USD","IBM","LEGN","CVX","SBUX","KGS","COGT","ARCO","LU0823421333.USD","LU2552382132.HKD","ALKS"],"gpt_icon":1},{"id":"2582727653","title":"BUZZ-U.S. STOCKS ON THE MOVE-ExxonMobil, Yatra, Venture Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2582727653","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582727653?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:13","pubTimestamp":1762956792,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-ExxonMobil, Yatra, Venture GlobalEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL6N3WO0IC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VLN","CWAN","LU0823421416.USD","LU2458330243.SGD","IBM","FTCI","COGT","LU0354030511.USD","BHVN","LU2750360997.AUD","CRMD","LU0109394709.USD","LU1883866441.USD","MBRX","CRWS","LU0321505868.SGD","LU0823434583.USD","LU0943347566.SGD","SG9999015945.SGD","ALKS","LU2552382132.HKD","LU2750360641.GBP","LU0823421333.USD","LU2471134879.HKD","LU2471134796.USD","LU0278409577.USD","VG","LU0823434740.USD","LU2471134523.USD","FLNG","VVX","KGS","CREX","LU2458330169.SGD","LU0456854461.SGD","YTRA","LU0109392836.USD","LCID","BBWI","LU0795875086.SGD","ARCO","LU0788109394.HKD","LU0300736492.USD","LU0096364046.USD","XOM","LU0882574055.USD","ARTV"],"gpt_icon":1},{"id":"2582379647","title":"Artiva Biotherapeutics Reports Positive AlloNK Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582379647","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582379647?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:52","pubTimestamp":1762951975,"startTime":"0","endTime":"0","summary":"An update from Artiva Biotherapeutics, Inc. ( ($ARTV) ) is now available. On November 12, 2025, Artiva Biotherapeutics announced positive initial s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/artiva-biotherapeutics-reports-positive-allonk-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/artiva-biotherapeutics-reports-positive-allonk-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2582376105","title":"Artiva Biotherapeutics announces safety, translational data from AlloNK","url":"https://stock-news.laohu8.com/highlight/detail?id=2582376105","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582376105?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:36","pubTimestamp":1762951000,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics (ARTV) announced positive initial safety and translational data from ongoing clinical trials of AlloNK in combination with r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-announces-safety-translational-data-from-allonk-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-announces-safety-translational-data-from-allonk-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2582375236","title":"Artiva Biotherapeutics Announces Positive Initial Data for AlloNK Cell Therapy in Autoimmune Disease Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2582375236","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582375236?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:20","pubTimestamp":1762950012,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Inc. announced positive initial safety and translational data from ongoing clinical trials of AlloNK , an allogeneic, off-the-shelf natural killer  cell therapy, in combination with rituximab or obinutuzumab for the treatment of autoimmune diseases. The results, which were presented during a company webcast, indicate that AlloNK was generally well tolerated and demonstrated deep B-cell depletion in outpatient and community settings. Artiva remains on track to share initial clinical response data and conduct regulatory interactions with the U.S. Food and Drug Administration  to align on the pivotal trial design for AlloNK in refractory rheumatoid arthritis  in the first half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDLdCM8Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD","BK4585","LU2095319765.USD","NDAQ","LU2210150020.SGD","BK4139","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","BK4588","ARTV","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2582754883","title":"Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion With Allonk® in Autoimmune Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2582754883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582754883?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:20","pubTimestamp":1762950000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUAB0QFBB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2582375545","title":"Artiva Biotherapeutics Q3 EPS $(0.88), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2582375545","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582375545?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:13","pubTimestamp":1762949618,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Q3 EPS $(0.88), Inline","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48799228/artiva-biotherapeutics-q3-eps-0-88-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}]}}